In an era of widespread genetic sequencing, the ability to edit and alter an organism’s DNA is a powerful way to explore the information within and how it guides biological function.
A paper from the University of Wisconsin-Madison in the August issue of the journal GENETICS takes genome editing to a new level in fruit flies, demonstrating a remarkable level of fine control and, importantly, the transmission of those engineered genetic changes across generations.
Both features are key for driving the utility and spread of an approach that promises to give researchers new insights into the basic workings of biological systems, including embryonic development, nervous system function, and the understanding of human disease.
“Genome engineering allows you to change gene function in a very targeted way, so you can probe function at a level of detail” that wasn’t previously possible, says Melissa Harrison, an assistant professor of biomolecular chemistry in the UW-Madison School of Medicine and Public Health and one of the three senior authors of the new study.
Disrupting individual genes has long been used as a way to study their roles in biological function and disease. The new approach, based on molecules that drive a type of bacterial immune response, provides a technical advance that allows scientists to readily engineer genetic sequences in very detailed ways, including adding or removing short bits of DNA in chosen locations, introducing specific mutations, adding trackable tags, or changing the sequences that regulate when or where a gene is active.
The approach used in the new study, called the CRISPR RNA/Cas9 system, has developed unusually fast. First reported just one year ago by scientists at the Howard Hughes Medical Institute and University of California, Berkeley, it has already been applied to most traditional biological model systems, including yeast, zebrafish, mice, the nematode C. elegans, and human cells. The Wisconsin paper was the first to describe it in fruit flies and to show that the resulting genetic changes could be passed from one generation to the next.
“There was a need in the community to have a technique that you could use to generate targeted mutations,” says Jill Wildonger, a UW-Madison assistant professor of biochemistry and another senior author of the paper. “The need was there and this was the technical advance that everyone had been waiting for.”
“The reason this has progressed so quickly is that many researchers — us included — were working on other, more complicated, approaches to do exactly the same thing when this came out,” adds genetics assistant professor Kate O’Connor-Giles, the third senior author. “This is invaluable for anyone wanting to study gene function in any organism and it is also likely to be transferable to the clinical realm and gene therapy.”
The CRISPR RNA/Cas9 system directs a DNA-clipping enzyme called Cas9 to snip the DNA at a targeted sequence. This cut then stimulates the cell’s existing DNA repair machinery to fill in the break while integrating the desired genetic tweaks. The process can be tailored to edit down to the level of a single base pair — the rough equivalent of changing a single letter in a document with a word processor.
The broad applicability of the system is aided by a relatively simple design that can be customized through creation of a short RNA sequence to target a specific sequence in the genome to generate the desired changes. Previous genome editing methods have relied on making custom proteins, which is costly and slow.
“This is so readily transferable that it’s highly likely to enable gene knockout and other genome modifications in any organism,” including those that have not previously been used for laboratory work, says O’Connor-Giles. “It’s going to turn non-model organisms into genetic model organisms.”
That ease may also pay off in the clinic. “It can be very difficult and time-consuming to generate models to study all the gene variants associated with human diseases,” says Wildonger. “With this genome editing approach, if we work in collaboration with a clinician to find [clinically relevant] mutations, we can rapidly translate these into a fruit fly model to see what’s happening at the cellular and molecular level.”
The Latest Bing News on:
- Big Island’s Owens gets $2.3M grant for genetic therapy researchon June 19, 2021 at 3:05 am
Jesse Owens was just 17 when he decided to devote his life to gene therapy research. Now the youngest full-time faculty member at John A. Burns School of Medicine’s Institute for Biogenesis Research, ...
- Verve’s shares soar as Cambridge biotech makes its stock market debuton June 17, 2021 at 1:31 pm
Verve sold more than 14 million shares in its IPO, raising nearly $267 million from investors enthusiastic about its novel approach to treating cardiovascular disease with the genome-editing tool ...
- Citizens’ jury set to reflect deeply on the pros and cons of human genome editingon June 16, 2021 at 10:53 pm
Two dozen ‘ordinary Aussies’ tackle whether scientists should be able to change our genes to prevent disease or create superhumans ...
- Hilo High alum awarded $2.3M for gene therapy researchon June 16, 2021 at 3:05 am
Photo courtesy of University of Hawaii Jesse Owens, assistant professor at the Institute for Biogenesis Research at the University of Hawaii John A. Burns School of Medicine and a Hilo High School ...
- Gene Editing Stocks: Should You Add This Cutting-Edge Sector To Your Portfolio?on June 15, 2021 at 11:10 pm
O ur indicative theme of Gene Editing stocks is down by about 12% year-to-date, compared to the S&P 500 which is up by over 13% over the same period. The decline comes as investors move money from ...
- PEW scholar builds on gene-editing technologyon June 15, 2021 at 5:40 am
Elizabeth Kellogg, assistant professor of molecular biology and genetics in the College of Arts and Sciences, has been named to the Pew Scholars ...
- ISSCR guidelines fudge heritable human-genome editingon June 15, 2021 at 2:49 am
I note troubling inconsistencies in the revised guidelines for stem-cell research and clinical translation, issued in May by the International Society for Stem Cell Research (ISSCR; see Nature 594, 18 ...
- Citizens’ Jury set to explore human genome editingon June 14, 2021 at 11:43 am
Citizens' Jury set to explore human genome editing Two dozen 'ordinary Aussies' tackle whether scientists should be able to change our genes to ...
- Bioethics Program Director Dr. Robert Klitzman Addresses Challenges of Human Genome Editingon June 10, 2021 at 7:55 am
Bioethics Program Director Robert Klitzman, M.D. has authored an editorial in The American Journal of Bioethics on the potential ethical problems posed by heritable human genome editing (HHGE). The ...
- New method to untangle 3D cancer genomeon June 10, 2021 at 4:47 am
Northwestern Medicine scientists have invented a new method for resolving rearranged chromosomes and their 3D structures in cancer cells, which can reveal key gene regulators that lead to the ...
The Latest Google Headlines on:
The Latest Bing News on:
- New Software Makes CRISPR Gene Editing as Easy as “Point-and-Click”on November 30, 2016 at 10:13 am
CRISPR technology has exploded over the past few years. This field of study is exponentially growing, as more and more scientists are developing their own software algorithms to make the CRISPR ...